Jack W. Schuler

Jack W. Schuler is a declared insider at 6 companies (board member); the most frequent names are Biodesix Inc, Accelerate Diagnostics, Inc and Aspira Women's Health Inc. We count 113 filings; the first trade dates from 15 January 2016 and the latest from 12 August 2026.

On the open market, the record shows 91 purchases worth €53.6M and 12 sales worth €489k. The totals exclude 29 filings filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 5 share grants and 4 option exercises. In 2026 alone, the filings show 7 purchases and no sales.

A typical purchase (the median) is worth €220k. As a share of market capitalisation, the median purchase stands at 0.12%, based on 5 purchases. Of 89 purchases, 23 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The latest filing, published on 13 August 2026, reports an open-market purchase of €318k in Biodesix Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.